Does CYCLOSPORINE Cause Tonsillar hypertrophy? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Tonsillar hypertrophy have been filed in association with CYCLOSPORINE (Verkazia). This represents 0.0% of all adverse event reports for CYCLOSPORINE.
12
Reports of Tonsillar hypertrophy with CYCLOSPORINE
0.0%
of all CYCLOSPORINE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Tonsillar hypertrophy From CYCLOSPORINE?
Of the 12 reports, 10 (83.3%) required hospitalization.
Is Tonsillar hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYCLOSPORINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does CYCLOSPORINE Cause?
Drug ineffective (11,172)
Off label use (6,860)
Eye irritation (5,806)
Product use in unapproved indication (5,019)
Condition aggravated (2,310)
Eye pain (2,197)
Drug intolerance (2,176)
Pneumonia (2,022)
Pyrexia (2,020)
Treatment failure (1,961)
What Other Drugs Cause Tonsillar hypertrophy?
ADALIMUMAB (151)
ONDANSETRON (51)
SOMATROPIN (43)
SECUKINUMAB (42)
DUPILUMAB (39)
METHOTREXATE (39)
INFLIXIMAB (31)
TACROLIMUS (26)
INFLIXIMAB-DYYB (25)
ETANERCEPT (24)
Which CYCLOSPORINE Alternatives Have Lower Tonsillar hypertrophy Risk?
CYCLOSPORINE vs CYCLOSPORINE A
CYCLOSPORINE vs CYMBALTA
CYCLOSPORINE vs CYNODON DACTYLON POLLEN
CYCLOSPORINE vs CYPROHEPTADINE
CYCLOSPORINE vs CYPROTERONE